{"id":30949,"date":"2026-05-22T17:35:17","date_gmt":"2026-05-22T12:05:17","guid":{"rendered":"https:\/\/www.aicerts.ai\/news\/"},"modified":"2026-05-22T17:35:21","modified_gmt":"2026-05-22T12:05:21","slug":"biotech-shake-up-ai-venture-funding-hits-500m","status":"publish","type":"news","link":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/","title":{"rendered":"Biotech Shake-Up: AI Venture Funding Hits $500M"},"content":{"rendered":"\n<p>Meanwhile, the renowned VC brings sourcing, diligence, and scale playbooks sharpened in software. Moreover, Lilly backs each portfolio company with its Catalyze360 laboratories, regulatory experts, and clinical infrastructure. Observers believe this industrial stack could cut years from drug development timelines.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/aicertswpcdn.blob.core.windows.net\/newsportal\/2026\/05\/lab-innovation-scene-6a103a3d65ea6.jpg\" alt=\"Research lab scene highlighting AI Venture Funding for biotech innovation\"\/><figcaption class=\"wp-element-caption\">Where funding meets real-world research and development.<\/figcaption><\/figure>\n\n\n\n<p>Therefore, executives across venture capital circles are asking what the partnership means for their own strategies. It also tracks how the collaboration might reshape global finance flows into therapeutic innovation. Finally, readers gain actionable steps, including professional certifications, to ride the coming wave.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Market Signals Intensify Rapidly<\/h2>\n\n\n\n<p>Global biotech deal tables reveal momentum building before the announcement. In&nbsp;2024, AI startups working on drug discovery attracted $4 billion, according to PitchBook. Consequently, analysts expected another blockbuster funding round, yet few predicted Lilly\u2019s solo commitment. Moreover, the single-LP model demonstrates how corporate balance sheets now power AI Venture Funding alongside traditional pools.<\/p>\n\n\n\n<p>Reuters further noted that Andreessen Horowitz had already raised more than $15 billion across other vehicles. Such dry powder signals confidence despite tighter finance markets and higher interest costs. These numbers illustrate the backdrop. In summary, market data set fertile ground. However, understanding the fund\u2019s structure clarifies why insiders call the move unprecedented.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Unique Fund Structure Explained<\/h2>\n\n\n\n<p>The Biotech Ecosystem Venture Fund uses a corporate-sponsored design. Here, Eli Lilly acts as sole limited partner, while Andreessen Horowitz serves as general partner. Additionally, the GP retains full investment discretion, according to public statements. Catalyze360 gives portfolio firms access to lab space, assays, and experienced drug developers.<\/p>\n\n\n\n<p>Consequently, startups receive capabilities usually unreachable until late clinical stages.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Capital pool: up to $500 million<\/li>\n\n\n\n<li>Stage focus: creation through growth<\/li>\n\n\n\n<li>Core themes: therapeutic platforms, novel modalities, engineering, and AI capabilities<\/li>\n\n\n\n<li>Support stack: Catalyze360 labs, Gateway Labs, ExplorR&amp;D<\/li>\n<\/ul>\n\n\n\n<p>Nevertheless, the agreement remains unusual within venture capital norms because one corporation funds the entire vehicle. STAT reporters called the move \u201cunusual\u201d and compared it with earlier pharma spinout funds. Experts label the partnership a flagship case of AI Venture Funding driven by a single corporate LP. Together, these mechanics redefine GP-LP collaboration. Next, we examine practical advantages for founders and investors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Strategic Advantages Outlined Clearly<\/h2>\n\n\n\n<p>Firstly, the fund offers long-dated, non-dilutive capital aligned with biotech development cycles. Secondly, companies tap Lilly\u2019s regulatory and clinical muscle, reducing execution risk. Furthermore, Andreessen Horowitz supplies product, talent, and go-to-market playbooks learned from software exits.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Faster IND filings through shared preclinical platforms<\/li>\n\n\n\n<li>Earlier revenue signals from partnered trials<\/li>\n\n\n\n<li>Cross-disciplinary teams blending wet-lab science and machine learning<\/li>\n<\/ul>\n\n\n\n<p>Therefore, founders gain a differentiated path compared with a standard funding round. Investors also enjoy clearer follow-on syndication, because a renowned VC leads diligence. Moreover, the arrangement strengthens Andreessen Horowitz\u2019s reputation as a bridge between code and biology. Such blended expertise has become emblematic of modern AI Venture Funding in life sciences. In short, strategic leverage appears strong. However, every model carries drawbacks demanding scrutiny.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Potential Drawbacks Raised Cautiously<\/h2>\n\n\n\n<p>Single-corporate backing introduces concentration risk. In contrast, diversified LP pools buffer shifting priorities. Consequently, portfolio companies may face uncertainty if Lilly realigns therapeutic focus. Additionally, future acquirers might view embedded options or rights as encumbrances.<\/p>\n\n\n\n<p>Some entrepreneurs prefer independent venture capital to preserve open exit channels. STAT sources warned that confidential IP clauses could deter certain AI startups from engaging. Nevertheless, both partners state that governance safeguards protect founder autonomy. Furthermore, Lilly positions Catalyze360 as optional, not mandatory. Skeptics argue that too much corporate control could blunt AI Venture Funding\u2019s intended flexibility. Overall, risks appear manageable yet real. Understanding these tensions helps assess broader implications.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Implications For AI Startups<\/h2>\n\n\n\n<p>AI-native biotech founders now face expanded choices when raising seed or Series A cash. Moreover, AI Venture Funding options now include corporates, multi-stage funds, and sector-specific accelerators. The $500 million vehicle could shift valuation benchmarks across early oncology and immunology deals. Furthermore, competing VC firms may form similar alliances with pharma or med-tech giants.<\/p>\n\n\n\n<p>Consequently, founders will weigh strategic perks against baggage from single-corporate influence. Investors tracking finance cycles should monitor whether exits remain open to rival drugmakers. Meanwhile, Andreessen Horowitz can channel proprietary deal flow to the fund, boosting quality and speed. Therefore, observers expect at least five disclosed investments by year-end, pending regulatory filings. Ultimately, the model expands the capital stack for algorithm-driven labs. Next, we consider possible industry outcomes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Possible Outcomes To Watch<\/h2>\n\n\n\n<p>Analysts outline three plausible scenarios.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Rapid portfolio growth followed by co-development deals with Lilly<\/li>\n\n\n\n<li>Spinout successes attracting diversified venture capital syndicates<\/li>\n\n\n\n<li>Slower deployment if macro finance conditions tighten further<\/li>\n<\/ol>\n\n\n\n<p>Additionally, the fund could catalyze mergers between data-rich AI startups and cash-rich biopharma incumbents. Subsequently, benchmarking returns against other AI Venture Funding vehicles will shape future fundraising terms. If public markets reopen, a later funding round could deliver outsized multiples for early investors. However, any stalled exits might deter copycat structures. Nevertheless, a16z\u2019s larger brand and Lilly\u2019s balance sheet provide resilience. Industry veterans view the experiment as a bellwether for global AI Venture Funding performance metrics. Overall, outcomes will hinge on first portfolio milestones. Professionals planning careers in this space can prepare through targeted education.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Upskill With AI Certifications<\/h3>\n\n\n\n<p>Executives, investors, and scientists need cross-functional fluency to evaluate complex term sheets. Furthermore, professionals can deepen strategic insight through the <a href=\"https:\/\/www.aicerts.ai\/certifications\/essentials\/ai-executive\">AI Executive\u2122 certification<\/a>. The program covers governance, venture capital mechanics, and data science essentials. Moreover, completing accredited coursework signals commitment to responsible finance innovation. Earning specialized credentials sharpens negotiation power when discussing AI Venture Funding terms with institutional backers. Such credentials fast-track conversations with leading funds. We now recap key themes.<\/p>\n\n\n\n<p>Andreessen Horowitz and Eli Lilly have rewritten the playbook for biotech investment. Their corporate-sponsored vehicle exemplifies how AI Venture Funding keeps evolving despite market volatility. Moreover, the structure blends deep pharma resources with seasoned VC discipline. Nevertheless, founders must balance strategic support against potential exit constraints and information asymmetry. Consequently, due diligence on governance terms remains critical. Investors and operators who master finance principles and regulatory science will capture the largest gains. Explore the linked certification to strengthen that mastery and join the next generation of biotech leaders.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Investors are redrawing biotech maps with unprecedented speed. However, January\u2019s announcement of a $500 million vehicle managed by Andreessen Horowitz raised the stakes. The fund, fully financed by Eli Lilly, positions itself at the intersection of biology and data. Consequently, many analysts view the move as a watershed moment for AI Venture Funding. Unlike a traditional funding round, the capital comes from a single pharmaceutical giant. <\/p>\n","protected":false},"featured_media":30946,"parent":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_yoast_wpseo_focuskw":"AI Venture Funding","_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"Discover why Andreessen Horowitz and Eli Lilly's $500M biotech vehicle signals a new era of AI Venture Funding for innovators worldwide.","_yoast_wpseo_canonical":""},"tags":[41192,41191,41193],"news_category":[4,6,7],"communities":[],"class_list":["post-30949","news","type-news","status-publish","has-post-thumbnail","hentry","tag-ai-venture-funding","tag-catalyze360","tag-vc","news_category-ai","news_category-machine-learning","news_category-prompt-engineering"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biotech Shake-Up: AI Venture Funding Hits $500M - AI CERTs News<\/title>\n<meta name=\"description\" content=\"Discover why Andreessen Horowitz and Eli Lilly&#039;s $500M biotech vehicle signals a new era of AI Venture Funding for innovators worldwide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotech Shake-Up: AI Venture Funding Hits $500M - AI CERTs News\" \/>\n<meta property=\"og:description\" content=\"Discover why Andreessen Horowitz and Eli Lilly&#039;s $500M biotech vehicle signals a new era of AI Venture Funding for innovators worldwide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/\" \/>\n<meta property=\"og:site_name\" content=\"AI CERTs News\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-22T12:05:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/aicertswpcdn.blob.core.windows.net\/newsportal\/2026\/05\/biotech-funding-meeting.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/\",\"url\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/\",\"name\":\"Biotech Shake-Up: AI Venture Funding Hits $500M - AI CERTs News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/aicertswpcdn.blob.core.windows.net\\\/newsportal\\\/2026\\\/05\\\/biotech-funding-meeting.jpg\",\"datePublished\":\"2026-05-22T12:05:17+00:00\",\"dateModified\":\"2026-05-22T12:05:21+00:00\",\"description\":\"Discover why Andreessen Horowitz and Eli Lilly's $500M biotech vehicle signals a new era of AI Venture Funding for innovators worldwide.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/#primaryimage\",\"url\":\"https:\\\/\\\/aicertswpcdn.blob.core.windows.net\\\/newsportal\\\/2026\\\/05\\\/biotech-funding-meeting.jpg\",\"contentUrl\":\"https:\\\/\\\/aicertswpcdn.blob.core.windows.net\\\/newsportal\\\/2026\\\/05\\\/biotech-funding-meeting.jpg\",\"width\":1024,\"height\":576,\"caption\":\"A closer look at the business side of biotech innovation and funding.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/biotech-shake-up-ai-venture-funding-hits-500m\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Biotech Shake-Up: AI Venture Funding Hits $500M\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/\",\"name\":\"Aicerts News\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/#organization\",\"name\":\"Aicerts News\",\"url\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/news_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/news_logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Aicerts News\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aicerts.ai\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotech Shake-Up: AI Venture Funding Hits $500M - AI CERTs News","description":"Discover why Andreessen Horowitz and Eli Lilly's $500M biotech vehicle signals a new era of AI Venture Funding for innovators worldwide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/","og_locale":"en_US","og_type":"article","og_title":"Biotech Shake-Up: AI Venture Funding Hits $500M - AI CERTs News","og_description":"Discover why Andreessen Horowitz and Eli Lilly's $500M biotech vehicle signals a new era of AI Venture Funding for innovators worldwide.","og_url":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/","og_site_name":"AI CERTs News","article_modified_time":"2026-05-22T12:05:21+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/aicertswpcdn.blob.core.windows.net\/newsportal\/2026\/05\/biotech-funding-meeting.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/","url":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/","name":"Biotech Shake-Up: AI Venture Funding Hits $500M - AI CERTs News","isPartOf":{"@id":"https:\/\/www.aicerts.ai\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/#primaryimage"},"image":{"@id":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/#primaryimage"},"thumbnailUrl":"https:\/\/aicertswpcdn.blob.core.windows.net\/newsportal\/2026\/05\/biotech-funding-meeting.jpg","datePublished":"2026-05-22T12:05:17+00:00","dateModified":"2026-05-22T12:05:21+00:00","description":"Discover why Andreessen Horowitz and Eli Lilly's $500M biotech vehicle signals a new era of AI Venture Funding for innovators worldwide.","breadcrumb":{"@id":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/#primaryimage","url":"https:\/\/aicertswpcdn.blob.core.windows.net\/newsportal\/2026\/05\/biotech-funding-meeting.jpg","contentUrl":"https:\/\/aicertswpcdn.blob.core.windows.net\/newsportal\/2026\/05\/biotech-funding-meeting.jpg","width":1024,"height":576,"caption":"A closer look at the business side of biotech innovation and funding."},{"@type":"BreadcrumbList","@id":"https:\/\/www.aicerts.ai\/news\/biotech-shake-up-ai-venture-funding-hits-500m\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aicerts.ai\/news\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.aicerts.ai\/news\/news\/"},{"@type":"ListItem","position":3,"name":"Biotech Shake-Up: AI Venture Funding Hits $500M"}]},{"@type":"WebSite","@id":"https:\/\/www.aicerts.ai\/news\/#website","url":"https:\/\/www.aicerts.ai\/news\/","name":"Aicerts News","description":"","publisher":{"@id":"https:\/\/www.aicerts.ai\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aicerts.ai\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.aicerts.ai\/news\/#organization","name":"Aicerts News","url":"https:\/\/www.aicerts.ai\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.aicerts.ai\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.aicerts.ai\/news\/wp-content\/uploads\/2024\/09\/news_logo.svg","contentUrl":"https:\/\/www.aicerts.ai\/news\/wp-content\/uploads\/2024\/09\/news_logo.svg","width":1,"height":1,"caption":"Aicerts News"},"image":{"@id":"https:\/\/www.aicerts.ai\/news\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/news\/30949","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/types\/news"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/comments?post=30949"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/media\/30946"}],"wp:attachment":[{"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/media?parent=30949"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/tags?post=30949"},{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/news_category?post=30949"},{"taxonomy":"communities","embeddable":true,"href":"https:\/\/www.aicerts.ai\/news\/wp-json\/wp\/v2\/communities?post=30949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}